ECM
KURA icon

Element Capital Management’s Kura Oncology KURA Stock Holding History

Element Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,693
Closed -$238K – 928
2018
Q1 		$238K Buy
+12,693
New +$247K 0.01% 592

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Element Capital Management's KURA Position: Q2 2018 in Review

Element Capital Management sold out of Kura Oncology (KURA) in Q2 2018, closing a stake of 12,693 shares — an estimated $238K sold.

Element Capital Management first reported a position in KURA in Q1 2018 and held it in 1 quarter. The position peaked at $238K in Q1 2018. 107 funds tracked by Wall St. Rank hold KURA as of Q2 2018.

  • Element Capital Management reported no remaining Kura Oncology position as of Q2 2018 after selling out during the quarter.
  • Element Capital Management sold 12,693 Kura Oncology shares in Q2 2018, an estimated $238K.
  • Element Capital Management first reported a position in Kura Oncology in Q1 2018 and held it in 1 quarter.
  • Element Capital Management's Kura Oncology position peaked at $238K in Q1 2018.
  • 107 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2018.

Based on Element Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.